# WARFARIN SODIUM
> **ANDA202202** · Abbreviated New Drug Application (Generic) · Sponsor: AMNEAL PHARMS · Approved 2013-03-04
## Drug
- **FDA Application Number:** ANDA202202
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** WARFARIN SODIUM
- **Generic name:** WARFARIN
- **Active ingredients:** WARFARIN SODIUM
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** AMNEAL PHARMS
- **Manufacturer:** Amneal Pharmaceuticals LLC
- **First approval:** 2013-03-04
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202202)
---
*AI Analytics · CC0 1.0*